CHEK - Check Cap Ltd
Check Cap Ltd Logo

CHEK - Check Cap Ltd

https://www.check-cap.com
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Check-Cap Ltd., a clinical-stage medical diagnostics company, is developing a capsule-based system that uses low-dose X-rays to scan the inner lining of the colon for precancerous polyps and other structural abnormalities in Israel. . The company is headquartered in Isfiya, Israel.

52W High
$3.04
52W Low
$0.56

MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.38
Valuation
As of 2024-09-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
0.74
EV/Revenue (<3 favorable)
N/A
P/S (TTM) (<3 favorable)
N/A
P/B (<3 favorable)
0.25
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
24.98%
Institutions (25–75% balanced)
2.07%
Shares Outstanding
5,851,000
Float
4,744,900
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2024-09-30 (Overview)
Revenue (TTM)
0
Gross Profit (TTM)
0
EPS (TTM)
-4.30
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
N/A
ROE (TTM) (>15% strong)
-2.26%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
N/A
Momentum
Value
N/A
Previous
N/A
Trend
Signal Cross
No cross

As of